Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Author's Reply to Comments to: Visual and Anatomic Outcomes after Conversion to Aflibercept in Neovascular Age-Related Macular Degeneration: 12-Month Results